0001761612-24-000003.txt : 20240612
0001761612-24-000003.hdr.sgml : 20240612
20240611175624
ACCESSION NUMBER: 0001761612-24-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20240612
DATE AS OF CHANGE: 20240611
EFFECTIVENESS DATE: 20240612
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS PLC
CENTRAL INDEX KEY: 0001761612
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-515738
FILM NUMBER: 241036976
BUSINESS ADDRESS:
STREET 1: BLOCKS A & B, PORTWAY BUILDING
STREET 2: GRANTA PARK, GREAT ABINGTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB21 6GS
BUSINESS PHONE: 011441223261503
MAIL ADDRESS:
STREET 1: BLOCKS A & B, PORTWAY BUILDING
STREET 2: GRANTA PARK, GREAT ABINGTON
CITY: CAMBRIDGE
STATE: X0
ZIP: CB21 6GS
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS plc
DATE OF NAME CHANGE: 20190530
FORMER COMPANY:
FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd
DATE OF NAME CHANGE: 20181212
D
1
primary_doc.xml
X0708
D
LIVE
0001761612
BICYCLE THERAPEUTICS PLC
BLOCKS A & B, PORTWAY BUILDING
GRANTA PARK, GREAT ABINGTON
CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
011441223261503
UNITED KINGDOM
BICYCLE THERAPEUTICS plc
BICYCLE THERAPEUTICS Ltd
Other
PUBLIC LIMITED COMPANY
true
KEVIN
LEE
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
Director
ALETHIA
YOUNG
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
PIERRE
LEGAULT
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
FELIX
J.
BAKER
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
JANICE
BOURQUE
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
JOSE-CARLOS
GUTIERREZ-RAMOS
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
RICHARD
N.
KENDER
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
STEPHEN
SANDS
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
GREGORY
WINTER
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Director
SANTIAGO
ARROYO
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
NIGEL
CROCKETT
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
MICHAEL
HANNAY
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
NICHOLAS
KEEN
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
ALISTAIR
MILNES
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
MICHAEL
SKYNNER
C/O BICYCLE THERAPEUTICS PLC
BLOCKS A&B PORTWAY BUILDING, GRANTA PARK
GREAT ABINGTON, CAMBRIDGE
X0
UNITED KINGDOM
CB21 6GS
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2024-05-28
false
true
false
0
JEFFERIES LLC
2347
None
None
520 MADISON AVENUE
NEW YORK
NY
NEW YORK
10022
CA
CALIFORNIA
CT
CONNECTICUT
MD
MARYLAND
MA
MASSACHUSETTS
MN
MINNESOTA
NY
NEW YORK
PA
PENNSYLVANIA
true
555499983
555499983
0
false
19
10110000
0
0
false
BICYCLE THERAPEUTICS PLC
/s/ ALETHIA YOUNG
ALETHIA YOUNG
CHIEF FINANCIAL OFFICER
2024-06-11